210 related articles for article (PubMed ID: 18216151)
1. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.
Sánchez-Lozada LG; Tapia E; Bautista-García P; Soto V; Avila-Casado C; Vega-Campos IP; Nakagawa T; Zhao L; Franco M; Johnson RJ
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F710-8. PubMed ID: 18216151
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Zhao L; Johnson RJ
Nephrol Dial Transplant; 2008 Apr; 23(4):1179-85. PubMed ID: 18048425
[TBL] [Abstract][Full Text] [Related]
3. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats.
Sánchez-Lozada LG; Tapia E; Jiménez A; Bautista P; Cristóbal M; Nepomuceno T; Soto V; Avila-Casado C; Nakagawa T; Johnson RJ; Herrera-Acosta J; Franco M
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F423-9. PubMed ID: 16940562
[TBL] [Abstract][Full Text] [Related]
4. Thiazide diuretics exacerbate fructose-induced metabolic syndrome.
Reungjui S; Roncal CA; Mu W; Srinivas TR; Sirivongs D; Johnson RJ; Nakagawa T
J Am Soc Nephrol; 2007 Oct; 18(10):2724-31. PubMed ID: 17855639
[TBL] [Abstract][Full Text] [Related]
5. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
[TBL] [Abstract][Full Text] [Related]
6. Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia.
Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Wessale JL; Zhao L; Johnson RJ
Nephron Physiol; 2008; 108(4):p69-78. PubMed ID: 18434753
[TBL] [Abstract][Full Text] [Related]
7. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
Minami M; Ishiyama A; Takagi M; Omata M; Atarashi K
Blood Press; 2005; 14(2):120-5. PubMed ID: 16036490
[TBL] [Abstract][Full Text] [Related]
8. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
[TBL] [Abstract][Full Text] [Related]
9. The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome.
Leibowitz A; Peleg E; Sharabi Y; Shabtai Z; Shamiss A; Grossman E
Am J Hypertens; 2008 Mar; 21(3):348-51. PubMed ID: 18219301
[TBL] [Abstract][Full Text] [Related]
10. Risk reduction therapy for syndrome X: comparison of several treatments.
Oron-Herman M; Sela BA; Rosenthal T
Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656
[TBL] [Abstract][Full Text] [Related]
11. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Palo WA; Eustace D; Vernillet L; Joseph-Ridge N
Arthritis Rheum; 2005 Mar; 52(3):916-23. PubMed ID: 15751090
[TBL] [Abstract][Full Text] [Related]
12. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
13. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats.
Tapia E; Cristóbal M; García-Arroyo FE; Soto V; Monroy-Sánchez F; Pacheco U; Lanaspa MA; Roncal-Jiménez CA; Cruz-Robles D; Ishimoto T; Madero M; Johnson RJ; Sánchez-Lozada LG
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F727-36. PubMed ID: 23303409
[TBL] [Abstract][Full Text] [Related]
15. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model.
Wu LY; Juan CC; Hwang LS; Hsu YP; Ho PH; Ho LT
Eur J Nutr; 2004 Apr; 43(2):116-24. PubMed ID: 15083319
[TBL] [Abstract][Full Text] [Related]
16. Metabolic stress with a high carbohydrate diet increases adiponectin levels.
Kamari Y; Grossman E; Oron-Herman M; Peleg E; Shabtay Z; Shamiss A; Sharabi Y
Horm Metab Res; 2007 May; 39(5):384-8. PubMed ID: 17533582
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols.
de Moura RF; Ribeiro C; de Oliveira JA; Stevanato E; de Mello MA
Br J Nutr; 2009 Apr; 101(8):1178-84. PubMed ID: 19007450
[TBL] [Abstract][Full Text] [Related]
18. The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model.
Kim HY; Okubo T; Juneja LR; Yokozawa T
Br J Nutr; 2010 Feb; 103(4):502-12. PubMed ID: 19878614
[TBL] [Abstract][Full Text] [Related]
19. Felodipine attenuates vascular inflammation in a fructose-induced rat model of metabolic syndrome via the inhibition of NF-kappaB activation.
Tan HW; Xing SS; Bi XP; Li L; Gong HP; Zhong M; Zhang Y; Zhang W
Acta Pharmacol Sin; 2008 Sep; 29(9):1051-9. PubMed ID: 18718174
[TBL] [Abstract][Full Text] [Related]
20. Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats.
Si X; Webb RC; Richey JM
Can J Physiol Pharmacol; 1999 Oct; 77(10):755-62. PubMed ID: 10588479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
